THIS IS AN ADVERTISEMENT

Xarelto

Blood thinners have been on the market for decades. For patients who need these drugs, blood thinners can be truly life-saving.

Xarelto (rivaroxaban) is a relatively new blood thinner being prescribed. Xarelto was first approved in July 2011 and is manufactured by Janssen Pharmaceuticals, a division of Johnson & Johnson. While bleeding is a common complication associated with the use of blood thinners, Xarelto is particularly dangerous as there is no antidote for it. If a patient experiences uncontrolled bleeding while on Xarelto, there is not a way to stop it and the condition can be life-threatening. This is not true for other anti-coagulants, such as Warfarin and Coumadin, whose side effects can be reversed through the administration of Vitamin K.

Drug manufacturers, such as Janssen Pharmaceuticals, have a duty to ensure the drugs that they manufacture, market, and sell are not dangerous. As Xarelto became more commonly used, a number of problems were discovered with the drug, prompting additional warning labels on the drug’s prescription packages. One warning specifically addresses the lack of antidote for the drug. The warnings also indicate that Xarelto can interact with other drugs, and that its use has not been studied in patients with prosthetic heart valves, and warns doctors not to use it on patients who have an artificial valve. All of the warnings about the drug can be read on this FDA web site.

ELPO is representing Kentucky and Tennessee patients and the families of those who have taken Xarelto and have suffered harm from this drug, and we’re not alone in doing so. Lawsuits are moving forward all over the country concerning Xarelto. The Madison-St. Clair Legal Record in Illinois wrote about a lawsuit filed in January 2015 by a woman whose blood no longer congeals in a timely manner. Other lawsuits allege brain bleeds, gastrointestinal bleeds and other significant bleeding events. Lawsuits against Janssen and Johnson & Johnson have been consolidated in courts in Pennsylvania and Louisiana.

If you have taken this drug or if you know of someone who has, we urge you to act quickly. We will provide a free consultation with you to help you decide if you are entitled to participate in the ongoing lawsuits concerning Xarelto. Please contact us at (270) 781-6500 or use our online form and ask to speak with one of our experienced drug injury attorneys.